High-throughput combinatorial screening further identified an H1L1A1B3 formulation that, when loaded with circRNA encoding interleukin-12 and delivered intratumorally, induced significant tumor regression in a Lewis lung carcinoma model, accompanied by increased infiltration of CD45-positive leukocytes and CD8-positive T cells [45]. This evidence concerns the gene CD8A and neoplasm.